Literature DB >> 31903578

Influence of propofol-based total intravenous anaesthesia on peri-operative outcome measures: a narrative review.

M G Irwin1, C K E Chung2, K Y Ip2, M D Wiles3.   

Abstract

Propofol-based total intravenous anaesthesia is well known for its smooth, clear-headed recovery and anti-emetic properties, but there are also many lesser known beneficial properties that can potentially influence surgical outcome. We will discuss the anti-oxidant, anti-inflammatory and immunomodulatory effects of propofol and their roles in pain, organ protection and immunity. We will also discuss the use of propofol in cancer surgery, neurosurgery and older patients.
© 2020 Association of Anaesthetists.

Entities:  

Keywords:  anaesthesia; cancer; intravenous; pain; propofol; surgery

Mesh：

Substances：

Year:  2020        PMID： 31903578     DOI： 10.1111/anae.14905

Source DB:  PubMed          Journal:  Anaesthesia        ISSN： 0003-2409            Impact factor:   6.955


  10 in total

1.  Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability.

Authors:  Gustavo H Oliveira-Paula; Fernanda Borchers Coeli-Lacchini; Letícia Perticarrara Ferezin; Graziele C Ferreira; Lucas C Pinheiro; Waynice N Paula-Garcia; Luis V Garcia; Jose E Tanus-Santos; Riccardo Lacchini
Journal:  Eur J Clin Pharmacol       Date:  2021-01-07       Impact factor: 2.953

2.  Total intravenous anesthesia for liver resections: anesthetic implications and safety.

Authors:  Selene Yan Ling Tan; Nian Chih Hwang
Journal:  Korean J Anesthesiol       Date:  2022-09-28

Review 3.  Hypoxia-dependent signaling in perioperative and critical care medicine.

Authors:  Kiichi Hirota
Journal:  J Anesth       Date:  2021-05-18       Impact factor: 2.078

4.  Effects of propofol on the proliferation and migration of liver cancer cells.

Authors:  Chan Li; Qingxia Fu; Jin Cai; Hongxia Mei; Wangning Shangguan
Journal:  Exp Ther Med       Date:  2021-05-09       Impact factor: 2.447

Review 5.  Association Between Anesthesia Delivered During Tumor Resection and Cancer Survival: a Systematic Review of a Mixed Picture with Constant Themes.

Authors:  Luke V Selby; Ana Fernandez-Bustamante; Aslam Ejaz; Ana Gleisner; Timothy M Pawlik; David J Douin
Journal:  J Gastrointest Surg       Date:  2021-06-07       Impact factor: 3.267

6.  Propofol suppresses lung cancer tumorigenesis by modulating the circ-ERBB2/miR-7-5p/FOXM1 axis.

Authors:  Jie Gao; Chengzhi Ding; Junhui Zhou; Gang Wu; Zongmao Han; Jianchao Li; Feilong Hei
Journal:  Thorac Cancer       Date:  2021-01-27       Impact factor: 3.500

7.  Propofol via Antioxidant Property Attenuated Hypoxia-Mediated Mitochondrial Dynamic Imbalance and Malfunction in Primary Rat Hippocampal Neurons.

Authors:  Jingfeng Han; Weiping Tao; Wei Cui; Jiawei Chen
Journal:  Oxid Med Cell Longev       Date:  2022-01-18       Impact factor: 6.543

8.  Propofol enhances stem-like properties of glioma via GABAAR-dependent Src modulation of ZDHHC5-EZH2 palmitoylation mechanism.

Authors:  Xiaoqing Fan; Meiting Gong; Huihan Yu; Haoran Yang; Sheng Wang; Ruiting Wang
Journal:  Stem Cell Res Ther       Date:  2022-08-04       Impact factor: 8.079

9.  A Comparison of the Effects of Prolonged Infusion of Propofol 2% and 1% During Total Intravenous Anaesthesia Using Target-Controlled Infusion Technique for Elective Neurosurgery.

Authors:  Kar Yee Loo; Sanihah Che Omar; Rhendra Hardy Mohamad Zaini; Wan Mohd Nazaruddin Wan Hassan; Praveena Seevaunnamtum
Journal:  Malays J Med Sci       Date:  2022-08-29

10.  Baseline Values and Kinetics of IL-6, Procalcitonin, and TNF-α in Landrace-Large White Swine Anesthetized with Propofol-Based Total Intravenous Anesthesia.

Authors:  Athanasios Chalkias; Vaios Spyropoulos; Georgia Georgiou; Eleni Laou; Anastasios Koutsovasilis; Ioannis Pantazopoulos; Konstantina Kolonia; Spyros Vrakas; Apostolos Papalois; Styliani Demeridou; Konstantinos Gourgoulianis; Ismene Dontas; George Kaparos; Stavroula Baka; Theodoros Xanthos
Journal:  Biomed Res Int       Date:  2021-06-19       Impact factor: 3.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.